Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice

J. Skoda, A. Nunukova, T. Loja, I. Zambo, J. Neradil, P. Mudry, K. Zitterbart, M. Hermanova, A. Hampl, J. Sterba, R. Veselska,

. 2016 ; 37 (7) : 9535-9548. [pub] 20160120

Language English Country United States

Document type Comparative Study, Journal Article

Persistent link   https://www.medvik.cz/link/bmc17014149

Grant support
NT13443 MZ0 CEP Register

The three most frequent pediatric sarcomas, i.e., Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma, were examined in this study: three cell lines derived from three primary tumor samples were analyzed from each of these tumor types. Detailed comparative analysis of the expression of three putative cancer stem cell markers related to sarcomas-ABCG2, CD133, and nestin-was performed on both primary tumor tissues and corresponding cell lines. The obtained results showed that the frequency of ABCG2-positive and CD133-positive cells was predominantly increased in the respective cell lines but that the high levels of nestin expression were reduced in both osteosarcomas and rhabdomyosarcomas under in vitro conditions. These findings suggest the selection advantage of cells expressing ABCG2 or CD133, but the functional tests in NOD/SCID gamma mice did not confirm the tumorigenic potential of cells harboring this phenotype. Subsequent analysis of the expression of common stem cell markers revealed an evident relationship between the expression of the transcription factor Sox2 and the tumorigenicity of the cell lines in immunodeficient mice: the Sox2 levels were highest in the two cell lines that were demonstrated as tumorigenic. Furthermore, Sox2-positive cells were found in the respective primary tumors and all xenograft tumors showed apparent accumulation of these cells. All of these findings support our conclusion that regardless of the expression of ABCG2, CD133 and nestin, only cells displaying increased Sox2 expression are directly involved in tumor initiation and growth; therefore, these cells fit the definition of the cancer stem cell phenotype.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014149
003      
CZ-PrNML
005      
20190918152842.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13277-016-4837-0 $2 doi
035    __
$a (PubMed)26790443
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Škoda, Jan $u Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech Republic. Department of Pediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. $7 xx0223687
245    10
$a Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice / $c J. Skoda, A. Nunukova, T. Loja, I. Zambo, J. Neradil, P. Mudry, K. Zitterbart, M. Hermanova, A. Hampl, J. Sterba, R. Veselska,
520    9_
$a The three most frequent pediatric sarcomas, i.e., Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma, were examined in this study: three cell lines derived from three primary tumor samples were analyzed from each of these tumor types. Detailed comparative analysis of the expression of three putative cancer stem cell markers related to sarcomas-ABCG2, CD133, and nestin-was performed on both primary tumor tissues and corresponding cell lines. The obtained results showed that the frequency of ABCG2-positive and CD133-positive cells was predominantly increased in the respective cell lines but that the high levels of nestin expression were reduced in both osteosarcomas and rhabdomyosarcomas under in vitro conditions. These findings suggest the selection advantage of cells expressing ABCG2 or CD133, but the functional tests in NOD/SCID gamma mice did not confirm the tumorigenic potential of cells harboring this phenotype. Subsequent analysis of the expression of common stem cell markers revealed an evident relationship between the expression of the transcription factor Sox2 and the tumorigenicity of the cell lines in immunodeficient mice: the Sox2 levels were highest in the two cell lines that were demonstrated as tumorigenic. Furthermore, Sox2-positive cells were found in the respective primary tumors and all xenograft tumors showed apparent accumulation of these cells. All of these findings support our conclusion that regardless of the expression of ABCG2, CD133 and nestin, only cells displaying increased Sox2 expression are directly involved in tumor initiation and growth; therefore, these cells fit the definition of the cancer stem cell phenotype.
650    _2
$a antigen AC133 $x metabolismus $7 D000071916
650    _2
$a ABC transportér z rodiny G, člen 2 $x metabolismus $7 D000070997
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a zvířata $7 D000818
650    _2
$a nádorové biomarkery $x metabolismus $7 D014408
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a nádorová transformace buněk $x metabolismus $x patologie $7 D002471
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední NOD $7 D016688
650    _2
$a myši SCID $7 D016513
650    _2
$a nádorové proteiny $x metabolismus $7 D009363
650    _2
$a nádorové kmenové buňky $x metabolismus $x patologie $7 D014411
650    _2
$a nestin $x metabolismus $7 D064231
650    _2
$a osteosarkom $x metabolismus $x patologie $7 D012516
650    _2
$a rhabdomyosarkom $x metabolismus $x patologie $7 D012208
650    _2
$a transkripční faktory SOXB1 $x metabolismus $7 D055748
650    _2
$a sarkom $x metabolismus $x patologie $7 D012509
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Nunukova, Alena $u Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Loja, Tomáš $u Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech Republic. $7 xx0112989
700    1_
$a Zambo, Iva $u 1st Institute of Pathologic Anatomy, St. Anne's University Hospital and School of Medicine, Masaryk University, Brno, Czech Republic. $7 xx0211296
700    1_
$a Neradil, Jakub $u Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech Republic. Department of Pediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech Republic. $7 xx0079539
700    1_
$a Múdry, Peter $u Department of Pediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech Republic. $7 xx0153990
700    1_
$a Zitterbart, Karel $u Department of Pediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech Republic. $7 xx0142630
700    1_
$a Hermanová, Markéta, $u 1st Institute of Pathologic Anatomy, St. Anne's University Hospital and School of Medicine, Masaryk University, Brno, Czech Republic. $d 1969- $7 xx0073982
700    1_
$a Hampl, Aleš, $u Department of Histology and Embryology, School of Medicine, Masaryk University, Brno, Czech Republic. $d 1962- $7 ola2002153626
700    1_
$a Štěrba, Jaroslav, $u Department of Pediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech Republic. $d 1962- $7 mzk2004237310
700    1_
$a Veselská, Renata, $u Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech Republic. veselska@sci.muni.cz. Department of Pediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech Republic. veselska@sci.muni.cz. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. veselska@sci.muni.cz. $d 1968- $7 mzk2003196540
773    0_
$w MED00008757 $t Tumour biology the journal of the International Society for Oncodevelopmental Biology and Medicine $x 1423-0380 $g Roč. 37, č. 7 (2016), s. 9535-9548
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26790443 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20190918153232 $b ABA008
999    __
$a ok $b bmc $g 1200614 $s 974927
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 37 $c 7 $d 9535-9548 $e 20160120 $i 1423-0380 $m Tumor biology $n Tumor Biol $x MED00008757
GRA    __
$a NT13443 $p MZ0
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Archiving options